We are live on !
Find out more
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.94%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.64B
AUM Growth
+$244M
(+10%)
Cap. Flow
+$55.9M
Cap. Flow % of AUM
Cap. Flow %
2.11%
Top 10 Holdings %
Top 10 Hldgs %
30.38%
Holding
727
New
40
Increased
101
Reduced
241
Closed
72
Avg Time Held
3.7
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Growth ETF
EFG
|
+$38M |
| 2 |
NVIDIA
NVDA
|
+$32.9M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$31.9M |
| 4 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$17.1M |
| 5 |
Eli Lilly
LLY
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$12.2M |
| 2 |
PayPal
PYPL
|
+$12.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11.6M |
| 4 |
Adobe
ADBE
|
+$10.7M |
| 5 |
Becton Dickinson
BDX
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Miscellaneous | 15.82% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.67% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.89B
| $14.5K | ﹤0.01% |
1,780
| – | – |
2022 Q1
8 quarters
|
|
552
Goodyear
GT
$1.19B
| $14.4K | ﹤0.01% |
1,050
| – | – |
2021 Q4
9 quarters
|
|
553
Welltower
WELL
$179B
| $14K | ﹤0.01% |
150
| – | – |
2021 Q4
9 quarters
|
|
554
Ballard Power Systems
BLDP
$492M
| $13.9K | ﹤0.01% |
5,000
| – | – |
2021 Q4
9 quarters
|
|
555
Invesco Senior Loan ETF
BKLN
$5.8B
| $13.7K | ﹤0.01% |
650
| – | – |
2022 Q3
6 quarters
|
|
556
iShares Future Exponential Technologies ETF
XT
$3.93B
| $13.7K | ﹤0.01% |
229
| – | – |
2022 Q3
6 quarters
|
|
557
AstraZeneca
AZN
$286B
| $13.6K | ﹤0.01% |
100
| – | – |
2021 Q4
9 quarters
|
|
558
iShares MBS ETF
MBB
$35.3B
| $13.4K | ﹤0.01% |
145
| – | – |
2022 Q1
8 quarters
|
|
559
GSK
GSK
$101B
| $13.2K | ﹤0.01% |
308
-80
| -21% | -$3.3K |
2022 Q4
5 quarters
|
|
560
Arbutus Biopharma
ABUS
$627M
| $12.9K | ﹤0.01% |
5,000
| – | – |
2021 Q4
9 quarters
|
|
561
iShares MSCI Pacific ex Japan ETF
EPP
$2.23B
| $12.8K | ﹤0.01% |
300
-3,330
| -92% | -$140K |
2021 Q4
9 quarters
|
|
562
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.71B
| $12.7K | ﹤0.01% |
1,539
| – | – |
2022 Q2
7 quarters
|
|
563
State Street SPDR S&P International Dividend ETF
DWX
$524M
| $12.6K | ﹤0.01% |
359
| – | – |
2021 Q4
9 quarters
|
|
564
Generac Holdings
GNRC
$11.3B
| $12.6K | ﹤0.01% |
100
| – | – |
2021 Q4
9 quarters
|
|
565
Core & Main
CNM
$8.3B
| $12.6K | ﹤0.01% |
+220
| New | +$10.1K |
2024 Q1
0 quarters
|
|
566
Workday
WDAY
$47.3B
| $12.3K | ﹤0.01% |
+45
| New | +$12.8K |
2024 Q1
0 quarters
|
|
567
Sanofi
SNY
$116B
| $12.1K | ﹤0.01% |
248
| – | – |
2021 Q4
9 quarters
|
|
568
DELISTED
Marathon Oil Corporation
MRO
| $11.9K | ﹤0.01% |
420
| – | – |
2021 Q4
9 quarters
|
|
569
Invesco Dorsey Wright Momentum ETF
PDP
$1.36B
| $11.9K | ﹤0.01% |
120
| – | – |
2022 Q2
7 quarters
|
|
570
Synchrony
SYF
$22.5B
| $11.7K | ﹤0.01% |
272
| – | – |
2021 Q4
9 quarters
|
|
571
Matthews International
MATW
$587M
| $11.2K | ﹤0.01% |
360
| – | – |
2022 Q4
5 quarters
|
|
572
Service Corp International
SCI
$10.2B
| $11.1K | ﹤0.01% |
150
| – | – |
2022 Q4
5 quarters
|
|
573
Ford
F
$47.6B
| $11K | ﹤0.01% |
830
-2,880
| -78% | -$34.9K |
2021 Q4
9 quarters
|
|
574
Equifax
EFX
$22B
| $11K | ﹤0.01% |
41
-9
| -18% | -$2.29K |
2021 Q4
9 quarters
|
|
575
DELISTED
Avangrid, Inc.
AGR
| $10.9K | ﹤0.01% |
300
| – | – |
2023 Q1
4 quarters
|
|
Similar funds
Cambridge Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Trust held 727 positions worth $2.64B, up 10% from $2.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Cambridge Trust's Q1 2024 filing shows 40 new, 101 increased, 241 reduced and 72 closed positions. Its largest new stake was Best Buy: 93,973 shares worth $7.71M. The largest sale was JPMorgan Equity Premium Income ETF, an estimated $12.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Financials.
- Cambridge Trust's largest Q1 2024 buy was Best Buy: 93,973 shares worth $7.71M.
- Cambridge Trust added most to iShares MSCI EAFE Growth ETF in Q1 2024, an estimated $38M increase.
- Cambridge Trust's biggest Q1 2024 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $12.2M.
- Cambridge Trust fully exited Marvell Technology in Q1 2024, selling an estimated $302K.
- Cambridge Trust's ten largest holdings make up 30% of its $2.64B portfolio in Q1 2024.
- Cambridge Trust opened 40 new positions and closed 72 in Q1 2024.
- Cambridge Trust's portfolio value rose 10% quarter-over-quarter to $2.64B.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.